bendamustine has been researched along with fosbretabulin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, L; Jia, JJ; Luo, L; Wang, G; Zheng, S; Zhong, Q; Zhong, X | 1 |
| Chen, C; He, L; Hu, M; Jia, J; Li, H; Wang, G; Xu, L; Yin, H; Zhang, W; Zheng, S; Zhong, Q | 1 |
| Chen, Y; He, L; Wang, G; Yin, H; Zheng, S; Zhong, Q | 1 |
3 other study(ies) available for bendamustine and fosbretabulin
| Article | Year |
|---|---|
Synthesis and anticancer activity evaluation of naphthalene-substituted triazole spirodienones.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Computer Simulation; Drug Screening Assays, Antitumor; Female; Humans; Male; Mice; Naphthalenes; Structure-Activity Relationship; Triazoles | 2021 |
Design, synthesis, and evaluation of a novel series of mono-indolylbenzoquinones derivatives for the potential treatment of breast cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Humans; Mice; Tumor Suppressor Protein p53 | 2022 |
Design, synthesis, and antitumor study of a series of novel 1-Oxa-4-azaspironenone derivatives.
Topics: Antineoplastic Agents; Aza Compounds; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Molecular Structure; Spiro Compounds; Structure-Activity Relationship | 2022 |